The company-sponsored survey of about 300 users supports plans for Revita, which Fractyl says kept about 80% of lost weight off at six months.
Recap by typeshit. Full story at Yahoo Finance.
The candidate blocks a signal behind appetite loss and high energy burn in cancer cachexia, where patients waste away even while eating.
The new preprint looks at whether symptom relief people report on GLP-1 medications comes from weight loss alone or something else.
Lilly says participants lost 44 to 47 pounds versus about 21 on Ozempic, with bigger A1C drops. It plans to file for approval in 2027.
Lilly reports people on retatrutide lost 44 to 47 pounds over 80 weeks versus about 21 on Ozempic. It plans to file for approval in 2027.
A short Facebook share with no context on who used the peptides, where it happened or what followed.
Q3 revenue hit $24.40 billion, up 39% from a year ago. China's reimbursement listing for Mounjaro helped drive international demand.
Loading…